2025年全球連網藥物輸送設備市場報告

預計未來幾年連網藥物輸送設備市場將呈指數級成長，到 2029 年將達到 218.1 億美元，年複合成長率(CAGR)為 23.9%。預測期內的成長可歸因於多種因素，例如慢性病患病率的上升、患者對遵醫囑治療方法的意識的提高、醫療保健IT基礎設施的蓬勃發展、對預防保健的日益重視以及實驗室和醫院廣泛採用連網型設備來管理電子健康記錄(EHR)。預測期內的主要趨勢包括研發活動增加、技術創新和設備連接性增強、機器學習和人工智慧的採用激增、整合 AR/VR 技術的遠距遠端醫療平台的採用日益廣泛以及醫療保健設備中電子技術的採用日益廣泛。

未來五年23.9%的成長率預測比我們先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會對慢性病管理構成重大挑戰，因為這會增加瑞典和芬蘭進口的智慧胰島素筆和吸入器的成本，降低治療依從性監測，並可能增加數位醫療技術的成本。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，關稅的影響可能更為廣泛。

遠端患者監護(RPM) 的重要性日益提升，預計將推動連網藥物輸送設備市場的成長。遠端患者監護是一種利用科技遠端監控患者健康和醫療數據的醫療保健服務方式。連網藥物輸送設備在提升遠距病人監護方面發揮關鍵作用，它能夠準確追蹤藥物使用情況和依從性，促進及時干預，並提供個人化護理管理。例如，美國數位健康解決方案提供者 Vivalink Inc. 於 2023 年 8 月開展的一項調查顯示，使用遠距病人監護 (RPM) 的臨床醫生比例顯著成長了 305%，從 2021 年的 20% 上升至如今的 81%，其中 84% 的用戶計劃在 2024 年擴大 RPM 的使用範圍。因此，遠端患者監護重要的地位正在推動連網藥物輸送設備市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球連網藥物輸送設備：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球連網藥物輸送設備市場：成長率分析
• 全球連網藥物輸送設備市場表現：規模與成長，2019-2024
• 全球連網藥物輸送設備市場預測：規模與成長，2024-2029 年，2034 年預測
• 全球連網藥物輸送設備：總潛在市場（TAM）

第6章 市場細分

• 全球連網藥物輸送設備市場：按類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
• 獨立組件和軟體
• 整合設備
• 全球連網藥物輸送設備市場：依技術、效能與預測，2019-2024 年、2024-2029 年、2034 年
• Bluetooth
• 近距離場通訊(NFC)
• 其他技術
• 全球連網藥物輸送設備市場：按管理、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 腸外
• 吸入
• 全球連網藥物傳輸設備市場：應用、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• 氣喘
• 慢性阻塞性肺病
• 糖尿病管理
• 其他用途
• 全球連網藥物輸送設備市場：按類型細分（獨立組件和軟體）、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 行動應用程式
• 連接模組
• 數據分析軟體
• 全球連網藥物輸送設備市場：依整合設備（類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 智慧吸入器
• 智慧型自動注射器
• 連接注射器
• 穿戴式藥物輸送裝置

第7章 區域和國家分析

• 全球連網藥物輸送設備市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
• 全球連網藥物輸送設備市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 連網藥物輸送設備市場：競爭格局
• 連網藥物輸送設備市場：公司簡介
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Novartis AG
• Medtronic PLC
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Novo Nordisk A/S
• Merck Group
• Becton Dickinson and Company
• GlaxoSmithKline PLC
• Phillips-Medisize Corporation
• AptarGroup Inc.
• Dexcom Inc.
• West Pharmaceutical Services Inc.
• Insulet Corporation
• OPKO Health Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年連網藥物輸送設備市場：哪些國家將提供新機會
• 2029年連網藥物輸送設備市場：細分市場帶來新機會
• 2029年連網藥物輸送設備市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Connected drug delivery devices are advanced pharmaceutical tools that employ digital technology to monitor, regulate, and oversee the dispensing of medications, thereby improving adherence and patient outcomes. These devices are capable of internet connectivity, enabling data exchange between patients and healthcare providers to monitor medication usage, adjust dosages, and enhance treatment strategies.

The primary categories of connected drug delivery devices encompass standalone components, software, and integrated devices. Standalone components and software denote software or hardware capable of functioning independently or separately from a medical device that generates or utilizes it. They leverage various technologies such as Bluetooth, near-field communication (NFC), and others. These devices cater to a range of routes of administration including parenteral and inhalational methods, and find applications in conditions like asthma, chronic obstructive pulmonary disease, diabetes management, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The connected drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides connected drug delivery devices market statistics, including connected drug delivery devices industry global market size, regional shares, competitors with a connected drug delivery devices market share, detailed connected drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the connected drug delivery devices industry. This connected drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The connected drug delivery devices market size has grown exponentially in recent years. It will grow from $7.48 billion in 2024 to $9.27 billion in 2025 at a compound annual growth rate (CAGR) of 23.9%. The growth in the historic period can be attributed to increased awareness of connected devices, increased importance of remote monitoring for medication adherence, increased patient engagement, widespread consumer adoption, the rapidly increasing cost of medical management.

The connected drug delivery devices market size is expected to see exponential growth in the next few years. It will grow to $21.81 billion in 2029 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, rising patient awareness about adherence to prescribed therapies, rapidly moving healthcare it infrastructure, increasing emphasis on preventive care, widespread adoption of connected devices in laboratories and hospitals for maintaining electronic health records (EHR). Major trends in the forecast period include increasing R&D activities, surge in technological innovation and the increasing connectivity of devices, soaring adoption of machine learning and artificial intelligence, rising implementation of telehealth platform integrated with AR/VR technologies, increasing adoption of electronic technology in healthcare devices.

The forecast of 23.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for chronic disease management by increasing costs of smart insulin pens and inhalers sourced from Sweden and Finland, potentially reducing treatment adherence monitoring and raising digital health technology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the connected drug delivery device market is anticipated to be propelled by the increasing significance of remote patient monitoring (RPM). Remote patient monitoring is a healthcare delivery method utilizing technology to monitor patient health and medical data from a distance. Connected drug delivery devices play a crucial role in enhancing RPM by enabling precise tracking of medication usage and adherence, facilitating timely interventions, and offering personalized care management. For example, a survey conducted by Vivalink Inc., a US-based digital health solutions provider, in August 2023, revealed a significant increase of 305% in clinicians utilizing RPM on patients, rising from 20% in 2021 to 81% presently, with 84% of these users planning to expand their RPM usage in 2024. Consequently, the growing importance of remote patient monitoring is propelling the growth of the connected drug delivery device market.

Major players in the connected drug delivery devices market are concentrating on developing innovative technologies, such as digital respiratory health solutions, to enhance their market profitability. Digital respiratory health solutions for connected drug delivery devices encompass technology-enabled devices facilitating medication delivery to the respiratory system while monitoring usage and health data to improve patient outcomes. For instance, in February 2022, AptarGroup Inc., a US-based manufacturer of dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital tool transforms traditional metered-dose inhalers into smart, connected devices, enhancing medication adherence and management for individuals with chronic respiratory conditions like asthma and COPD. It incorporates features such as sensors for analytics and insights, supporting patient adherence monitoring via the BreatheSmart app, thereby aiding in the effective management of respiratory diseases.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for an undisclosed sum. This acquisition is expected to bolster Halozyme's strategy, solidify its position as a top drug delivery firm, and expand its coverage of specialized products with its best-in-class auto-injector technology and specialty commercial business. Antares Pharma Inc. is a US-based specialty pharmaceutical company operating in the connected drug delivery sector.

Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.

North America was the largest region in the connected drug delivery market in 2024. The regions covered in connected drug delivery device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the connected drug delivery device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The connected drug delivery device market consists of revenues earned by entities by providing services such as medication reminders and alerts, dose tracking, data sharing, adjustable dosing, and integration with health records. The market value includes the value of related goods sold by the service provider or included within the service offering. The connected drug delivery device market also includes sales of smart inhalers, connected insulin pumps, smart pill dispensers, wearable drug delivery devices, and digital pills that are used in providing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Connected Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on connected drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for connected drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The connected drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Standalone Components And Software; Integrated Devices
• 2) By Technology: Bluetooth; Near-Field Communication (NFC); Other Technologies
• 3) By Administration: Parenteral; Inhalational
• 4) By Application: Asthma; Chronic Obstructive Pulmonary Disease; Diabetes Management; Other Applications
• Subsegments:
• 1) By Standalone Components And Software: Mobile Applications; Connectivity Modules; Data Analytics Software
• 2) By Integrated Devices: Smart Inhalers; Smart Auto-injectors; Connected Syringes; Wearable Drug Delivery Devices
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; AstraZeneca PLC; Abbott Laboratories; Novartis AG; Medtronic PLC; Eli Lilly and Company; Amgen Inc.; Boehringer Ingelheim International GmbH; Novo Nordisk A/S; Merck Group; Becton Dickinson and Company; GlaxoSmithKline PLC; Phillips-Medisize Corporation; AptarGroup Inc.; Dexcom Inc.; West Pharmaceutical Services Inc.; Insulet Corporation; OPKO Health Inc.; Tandem Diabetes Care Inc.; Ypsomed AG; Meridian Medical Technologies LLC; Propeller Health; Findair Sp. z.o.o
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Connected Drug Delivery Devices Market Characteristics

3. Connected Drug Delivery Devices Market Trends And Strategies

4. Connected Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Connected Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Connected Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Connected Drug Delivery Devices Market Growth Rate Analysis
• 5.4. Global Connected Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Connected Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Connected Drug Delivery Devices Total Addressable Market (TAM)

6. Connected Drug Delivery Devices Market Segmentation

• 6.1. Global Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standalone Components And Software
• Integrated Devices
• 6.2. Global Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bluetooth
• Near-Field Communication (NFC)
• Other Technologies
• 6.3. Global Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral
• Inhalational
• 6.4. Global Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease
• Diabetes Management
• Other Applications
• 6.5. Global Connected Drug Delivery Devices Market, Sub-Segmentation Of Standalone Components And Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mobile Applications
• Connectivity Modules
• Data Analytics Software
• 6.6. Global Connected Drug Delivery Devices Market, Sub-Segmentation Of Integrated Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Smart Inhalers
• Smart Auto-injectors
• Connected Syringes
• Wearable Drug Delivery Devices

7. Connected Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Connected Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Connected Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Connected Drug Delivery Devices Market

• 8.1. Asia-Pacific Connected Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Connected Drug Delivery Devices Market

• 9.1. China Connected Drug Delivery Devices Market Overview
• 9.2. China Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Connected Drug Delivery Devices Market

• 10.1. India Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Connected Drug Delivery Devices Market

• 11.1. Japan Connected Drug Delivery Devices Market Overview
• 11.2. Japan Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Connected Drug Delivery Devices Market

• 12.1. Australia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Connected Drug Delivery Devices Market

• 13.1. Indonesia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Connected Drug Delivery Devices Market

• 14.1. South Korea Connected Drug Delivery Devices Market Overview
• 14.2. South Korea Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Connected Drug Delivery Devices Market

• 15.1. Western Europe Connected Drug Delivery Devices Market Overview
• 15.2. Western Europe Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Connected Drug Delivery Devices Market

• 16.1. UK Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Connected Drug Delivery Devices Market

• 17.1. Germany Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Connected Drug Delivery Devices Market

• 18.1. France Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Connected Drug Delivery Devices Market

• 19.1. Italy Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Connected Drug Delivery Devices Market

• 20.1. Spain Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Connected Drug Delivery Devices Market

• 21.1. Eastern Europe Connected Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Connected Drug Delivery Devices Market

• 22.1. Russia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Connected Drug Delivery Devices Market

• 23.1. North America Connected Drug Delivery Devices Market Overview
• 23.2. North America Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Connected Drug Delivery Devices Market

• 24.1. USA Connected Drug Delivery Devices Market Overview
• 24.2. USA Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Connected Drug Delivery Devices Market

• 25.1. Canada Connected Drug Delivery Devices Market Overview
• 25.2. Canada Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Connected Drug Delivery Devices Market

• 26.1. South America Connected Drug Delivery Devices Market Overview
• 26.2. South America Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Connected Drug Delivery Devices Market

• 27.1. Brazil Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Connected Drug Delivery Devices Market

• 28.1. Middle East Connected Drug Delivery Devices Market Overview
• 28.2. Middle East Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Connected Drug Delivery Devices Market

• 29.1. Africa Connected Drug Delivery Devices Market Overview
• 29.2. Africa Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Connected Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Connected Drug Delivery Devices Market Competitive Landscape
• 30.2. Connected Drug Delivery Devices Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Connected Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Medtronic PLC
• 31.3. Eli Lilly and Company
• 31.4. Amgen Inc.
• 31.5. Boehringer Ingelheim International GmbH
• 31.6. Novo Nordisk A/S
• 31.7. Merck Group
• 31.8. Becton Dickinson and Company
• 31.9. GlaxoSmithKline PLC
• 31.10. Phillips-Medisize Corporation
• 31.11. AptarGroup Inc.
• 31.12. Dexcom Inc.
• 31.13. West Pharmaceutical Services Inc.
• 31.14. Insulet Corporation
• 31.15. OPKO Health Inc.

32. Global Connected Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Connected Drug Delivery Devices Market

34. Recent Developments In The Connected Drug Delivery Devices Market

35. Connected Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 35.1 Connected Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Connected Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Connected Drug Delivery Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer